Pollyea DA, Winters A, McMahon C, Schwartz M, et al. Venetoclax and azacitidine followed by allogeneic transplant results in excellent outcomes and may improve outcomes versus maintenance therapy among newly diagnosed AML patients older than 60. Bone Marrow Transplant 2022;57:160-166.
PMID: 34645926